BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 21277980)

  • 1. Transplantation of adipose tissue protects BB/OK rats from type 1 diabetes development.
    Bahr J; Klöting N; Klöting I; Follak N
    Transpl Immunol; 2011 May; 24(4):238-40. PubMed ID: 21277980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-fat diet protects BB/OK rats from developing type 1 diabetes.
    Bahr J; Klöting N; Wilke B; Klöting I; Follak N
    Diabetes Metab Res Rev; 2011 Sep; 27(6):552-6. PubMed ID: 21523881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of sex and phenotype of parents on the incidence of diabetes in BB/OK rat litters.
    Klöting I; Vogt L
    Diabete Metab; 1993; 19(1 Pt 2):178-82. PubMed ID: 8314423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Congenic diabetes-prone BB.Sa and BB.Xs rats differ from their progenitor strain BB/OK in frequency and severity of insulin-dependent diabetes mellitus.
    van den Brandt J; Kovács P; Klöting I
    Biochem Biophys Res Commun; 1999 Oct; 263(3):843-7. PubMed ID: 10512768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes per se and metabolic state influence gene expression in tissue-dependent manner of BB/OK rats.
    Klöting N; Follak N; Klöting I
    Diabetes Metab Res Rev; 2005; 21(3):281-7. PubMed ID: 15619288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occurrence of islet cell reactive autoantibodies in diabetes-prone BB/OK rats is not associated with the onset of diabetes: a cross-sectional study of BB rats and their diabetes-resistant congenic strains.
    Schlosser M; Ziegler B; Augstein P; Klöting I; Ziegler M
    Diabetes Res; 1994; 26(2):67-77. PubMed ID: 7554727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is there an autoimmune process in bone? Gene expression studies in diabetic and nondiabetic BB rats as well as BB rat-related and -unrelated rat strains.
    Klöting N; Follak N; Klöting I
    Physiol Genomics; 2005 Dec; 24(1):59-64. PubMed ID: 16189279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variation in the multifunctional transcription factor Yy1 and type 1 diabetes mellitus in the BB rat.
    Klöting N; Klöting I
    Mol Genet Metab; 2004 Jul; 82(3):255-9. PubMed ID: 15234341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genes of SHR rats protect spontaneously diabetic BB/OK rats from diabetes: lessons from congenic BB.SHR rat strains.
    Klöting I; van den Brandt J; Kuttler B
    Biochem Biophys Res Commun; 2001 May; 283(2):399-405. PubMed ID: 11327715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coat colour phenotype, leucopenia, and insulin-dependent diabetes mellitus (IDDM) in BB rats.
    Kloeting I; Vogt L
    Diabetes Res; 1990 Sep; 15(1):37-9. PubMed ID: 2132199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Model-based prediction of diabetes incidence in BB/OK rats.
    Vogt L; Klöting I
    Diabete Metab; 1993; 19(1 Pt 2):183-7. PubMed ID: 8314424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of antibodies against both isoforms of glutamate decarboxylase in BB/OK rats by western blotting and immuno trapping enzyme activity assay.
    Lühder F; Woltanski KP; Hamann J; Klöting I; Ziegler B; Ziegler M
    Diabetes Res; 1992; 20(4):97-107. PubMed ID: 1345008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histomorphometric evaluation of the influence of the diabetic metabolic state on bone defect healing depending on the defect size in spontaneously diabetic BB/OK rats.
    Follak N; Klöting I; Wolf E; Merk H
    Bone; 2004 Jul; 35(1):144-52. PubMed ID: 15207750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement-dependent antibody-mediated cytotoxicity in the spontaneously diabetic BB/OK rat: association with beta cell volume density.
    Hehmke B; Lucke S; Schröder D; Klöting I; Kohnert KD
    Eur J Immunol; 1990 May; 20(5):1091-6. PubMed ID: 2192902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping of novel genes predisposing or protecting diabetes development in the BB/OK rat.
    Klöting I; Schmidt S; Kovacs P
    Biochem Biophys Res Commun; 1998 Apr; 245(2):483-6. PubMed ID: 9571179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Locus on chromosome 18 cosegregates with diabetes in the BB/OK rat subline.
    Klöting I; Vogt L; Serikawa T
    Diabete Metab; 1995 Dec; 21(5):338-44. PubMed ID: 8586150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humoral-mediated cytotoxicity to rat pancreatic exocrine cells in serum of diabetes-prone BB/OK rats--predictive value for diabetes onset.
    Schröder D; Hehmke B; Klöting I; Schmidt S
    Diabetes Res; 1993; 23(3):105-13. PubMed ID: 7712684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of type 1 diabetes in BB rats with recombinant human tumor necrosis factor-alpha.
    Satoh J; Seino H; Shintani S; Tanaka S; Ohteki T; Masuda T; Nobunaga T; Toyota T
    J Immunol; 1990 Sep; 145(5):1395-9. PubMed ID: 2384663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective investigations of long-term normoglycaemic BB/OK-rats: serial determination of glucose tolerance, insulitis, B-cell volume density and pancreatic insulin content.
    Hahn HJ; Lucke S; Klöting I; Besch W
    Exp Clin Endocrinol; 1991; 98(3):185-92. PubMed ID: 1778238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic studies of IDDM in BB rats: the incidence of diabetes in F2 and first backcross hybrids allows rejection of the recessive hypothesis.
    Klöting I; Stark O
    Exp Clin Endocrinol; 1987 Aug; 89(3):312-8. PubMed ID: 3666049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.